Brandywine Global Investment Management’s Strata Critical Medical Inc SRTA Stock Holding History

Brandywine Global Investment Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-360,300	Closed	-$1.25M	–	576
2024 Q3	$1.25M	Sell	360,300 -153,800	-30%	-$490K	0.01%	582
2024 Q2	$1.79M	Buy	514,100 +67,300	+15%	+$224K	0.01%	563
2024 Q1	$1.27M	Hold	446,800	–	–	0.01%	613
2023 Q4	$1.58M	Sell	446,800 -89,100	-17%	-$256K	0.01%	601
2023 Q3	$1.39M	Buy	535,900 +10,300	+2%	+$36.2K	0.01%	596
2023 Q2	$2.07M	Sell	525,600 -2,300	-0.4%	-$7.3K	0.02%	542
2023 Q1	$1.78M	Hold	527,900	–	–	0.01%	565
2022 Q4	$1.89M	Hold	527,900	–	–	0.01%	561
2022 Q3	$2.13M	Buy	+527,900	New	+$2.71M	0.02%	532

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Brandywine Global Investment Management's SRTA Position: Q4 2024 in Review

Brandywine Global Investment Management sold out of Strata Critical Medical Inc (SRTA) in Q4 2024, closing a stake of 360,300 shares — an estimated $1.25M sold.

Brandywine Global Investment Management first reported a position in SRTA in Q3 2022 and held it in 9 quarters. The position peaked at $2.13M in Q3 2022. 122 funds tracked by Wall St. Rank hold SRTA as of Q4 2024.

Brandywine Global Investment Management reported no remaining Strata Critical Medical Inc position as of Q4 2024 after selling out during the quarter.
Brandywine Global Investment Management sold 360,300 Strata Critical Medical Inc shares in Q4 2024, an estimated $1.25M.
Brandywine Global Investment Management first reported a position in Strata Critical Medical Inc in Q3 2022 and held it in 9 quarters.
Brandywine Global Investment Management's Strata Critical Medical Inc position peaked at $2.13M in Q3 2022.
122 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2024.

Based on Brandywine Global Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.